BETOPTIC 0.5% Price in UAE

Overview

Welcome to Dwaey, specifically on BETOPTIC 0.5% page.
This medicine contains an important and useful components, as it consists of
Betaxolol (as HCl)is available in the market in concentration

Name

Betaxolol 0.25% Eye prep

Precaution

DM, renal or hepatic impairment. May mask signs of hypoglycemia & hyperthyroidism. Gradual withdrawal is recommended. Children. Lactation.

Indication

Glaucoma, Ocular hypertension

Contra indication

Hypersensitivity. Sinus bradycardia, cardiogenic shock, overt cardiac failure. Pregnancy .

Side Effect

>10% Ocular effects Short term discomfort (<25%) Frequency Not Defined Ocular Blurred vision,Corneal punctate keratitis,Itching and/or foreign body sensation erythema,Inflammation,Ocular pain and/or discharge,Ocular drynes,Photophobia Systemic Bradycardia, congestive heart failure, heart block,Depression, dizziness, headache, insomnia, lethargy, vertigo,Hair loss, hives, toxic epidermal necrolysis Glossitis,Bronchospasm, dyspnea,Increase in signs and symptoms of myasthenia gravis

Pregnancy Category ID

Mode of Action

Betaxolol is a cardioselective Beta-blocker which has greater affinity for ?1-receptors and has little or no effect on ?2-receptors. It lacks intrinsic sympathomimetic but has little membrane-stabilising activity. It also causes the reduction of intraocular pressure by decreasing the production of aqueous humour.

Interaction

Increased risk of bradycardia w/ digitalis glycosides. May cause mydriasis w/ epinephrine. Potential additive effect w/ oral Ca channel blockers, ?-adrenergic blockers, antiarrhythmics (including amiodarone), parasympathomimetics, guanethidine. Increased risk of myocardial depression and hypotension w/ peripheral muscle relaxants (e.g. tubocurarine).